GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Small and Large Bowel/Severe Diverticulitis Among Younger Americans
61

Severe Diverticulitis Among Younger Americans

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated November 1, 2025

The rise in severe diverticulitis among younger Americans is a concerning trend that reflects significant shifts in the disease's epidemiology. Traditionally associated with older adults, diverticulitis is now increasingly affecting individuals under 50. A large-scale study analyzing 5.2 million hospitalizations from the National Inpatient Sample revealed a 52% relative increase in severe (complicated) cases among younger patients between 2005 and 2020. This shift suggests that the disease may be presenting more aggressively in younger individuals, with a higher likelihood of requiring invasive interventions such as colectomy (29% more likely) or percutaneous drainage (58% more likely) compared to older adults.

Despite the growing severity, surgical intervention rates for younger patients have declined significantly (from 34.7% to 20.3%), indicating improved disease management and more conservative treatment approaches. Younger patients also experience better outcomes, including lower mortality rates, shorter hospital stays, and reduced hospitalization costs compared to older individuals. However, the phenotype of the disease appears to differ in younger adults, potentially reflecting a more aggressive presentation or unique clinical management challenges.

The underlying causes of this trend remain unclear but may involve lifestyle factors, dietary changes, obesity, and environmental influences. Given the parallel rise in early-onset colorectal cancer, further research is urgently needed to understand and address the drivers of early-onset diverticulitis in this demographic.

Related Q&A

62

Long-Acting GLP-2 Analogue (Glepaglutide) and Short Bowel Syndrome

Glepaglutide is a long-acting GLP-2 (glucagon-like peptide-2) analogue designed to improve intestinal function and absorption in patients with short bowel syndrome (SBS). SBS is a condition characterized by...

63

Ileal Pouch Anal Anastomosis and Pouch Neoplasm

Ileal Pouch-Anal Anastomosis (IPAA): Ileal Pouch-Anal Anastomosis (IPAA) is a surgical procedure typically performed to restore bowel continuity after the removal of the colon and rectum. It is...

64

Ergosterol, visceral hypersensitivity and IBS

Ergosterol: Ergosterol is a naturally occurring sterol compound found in fungi, particularly in fungal cell membranes. Structurally, it is similar to cholesterol, which is found in animal cells....

65

FIREFLI ingestible capsule enable luminance-based diagnosis of acute mesenteric ischemia,

Yes, the FIREFLI ingestible capsule is a groundbreaking device that enables luminance-based diagnosis of acute mesenteric ischemia (AMI). AMI is a severe condition caused by insufficient blood flow...

66

Hyperbaric oxygen therapy for radiation enteritis

Hyperbaric oxygen therapy (HBOT) has emerged as a promising treatment for radiation enteritis (RE), a debilitating complication affecting up to 80% of patients undergoing pelvic radiotherapy, with 5–20%...

67

Colorectal polyps in patients with limited life expectancy - BSG View

The British Society of Gastroenterology (BSG) provides guidance for managing colorectal polyps in patients with a life expectancy of less than 10 years, focusing on balancing the risks...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer